Skip to main content
. Author manuscript; available in PMC: 2016 Apr 25.
Published in final edited form as: Eur J Haematol. 2015 Mar 16;96(1):27–35. doi: 10.1111/ejh.12541

Table 1.

Patient, donor, and graft characteristics

Median age (yr) 47 (25–60)
Diagnosis
  DLBCL 2 (18.2%)
  T-NHL 2 (18.2%)
  MM 2 (18.2%)
  HL 2 (18.2%)
  MCL 2 (18.2%)
  MZL 1 (9%)
Prior therapies (median) 4 (2–9)
Prior auto-SCT 10 (91%)
Auto to allo-SCT (median days) 375 (82–920)
Disease state pre-allo-SCT
  PR 9 (82%)
  SD 1 (9%)
  CR 1 (9%)
Donor
  MRD 6 (55%)
  MUD 4 (36%)
  mMUD 1 (9%)
Median CD34 dose (x106/kg) 4.9 (4, 1–13)

MUD, matched unrelated donor; mMRD, mismatched related donor; mMUD, mismatched unrelated donor.